ASTEC LIFESCIENCES LIMITED - 533138 - Re-Appointment Of Mr. Anurag Roy As The "Whole Time Director & Chief Executive Officer" Of The Company, Subject To Approval Of Shareholders.
Re-appointment of Mr. Anurag Roy as the "Whole Time Director & Chief Executive Officer" of the Company, subject to the approval of Shareholders. ASTEC LIFESCIENCES LIMITED - 533138 - Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Nine Months'' Period Ended December 31, 2023.
Kindly find enclosed the Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Nine Months'' period ended December 31, 2023 approved in the Board Meeting held by Astec LifeSciences Limited on January 25, 2024. ASTEC LIFESCIENCES LIMITED - 533138 - Board Meeting Outcome for Outcome Of The Board Meeting Held On January 25, 2024
Kindly find enclosed the Outcome of the Board Meeting held by Astec LifeSciences Limited on January 25, 2024. ASTEC LIFESCIENCES LIMITED - 533138 - Board Meeting Intimation for Intimation Of Board Meeting As Per Regulation 29 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
ASTEC LIFESCIENCES LIMITEDhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/01/2024 ,inter alia, to consider and approve Notice is hereby given pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), that the Meeting of the Board of Directors of Astec LifeSciences Limited ('the Company') is scheduled to be held on Thursday, 25th January, 2024, to, inter alia, consider and approve the Standalone and Consolidated Unaudited Financial Results for the Quarter and Nine Months' period ended 31st December, 2023, after these results are reviewed by the Audit Committee. ASTEC LIFESCIENCES LIMITED - 533138 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find enclosed Compliance Certificate received from Bigshare Services Private Limited, Registrar and Share Transfer Agent of Astec LifeSciences Limited for the Quarter ended December 31, 2023. ASTEC LIFESCIENCES LIMITED - 533138 - Closure of Trading Window
The Trading Window for dealing in the Securities of the Company will be closed with effect from Monday, January 1, 2024 till 48 hours after the declaration of the Unaudited Financial Results of the Company for the Quarter and Nine Months'' period ending December 31, 2023. ASTEC LIFESCIENCES LIMITED - 533138 - Disclosure Of The Details Of The Order Dated 3Rd October, 2023, Received From The Office Of The Commissioner Of Central Goods & Service Tax And Central Excise, Raigad.
Further to the intimation dated 7th December, 2023, please find enclosed the details of the order dated 3rd October, 2023, received on 6th December, 2023 from the office of the Commissioner of Central Goods & Service Tax and Central Excise, Raigad ASTEC LIFESCIENCES LIMITED - 533138 - Intimation Of Receipt Of An Order Dated 3Rd October, 2023, From The Office Of The Commissioner Of Central Goods & Service Tax And Central Excise, Raigad.
This is to inform you under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, that Astec LifeSciences Limited ("Company" / "Astec") has, on 6th December, 2023, received an order dated 3rd October 2023, from the Commissioner of Central Goods and Service Tax and Excise, Raigad, confirming levy of Central Excise Duty of Rs. 0.64 Crore, payable along with interest thereon and imposing a penalty of Rs.0.64 Crore for short payment at the time of debonding. The Company is considering filing an appeal against the said order. ASTEC LIFESCIENCES LIMITED - 533138 - Announcement under Regulation 30 (LODR)-Newspaper Publication
kindly find enclosed the copies of the newspaper publications of the unaudited financial results for the quarter and Half Year ended September 30, 2023.
